DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 203 filers reported holding DIPLOMAT PHARMACY INC in Q1 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $1,511,000 | +53.9% | 75,000 | +119.4% | 0.15% | -78.3% |
| Q3 2015 | $982,000 | +171.3% | 34,190 | +322.1% | 0.67% | +541.0% |
| Q2 2015 | $362,000 | -47.7% | 8,100 | -59.5% | 0.10% | -58.5% |
| Q1 2015 | $692,000 | +152.6% | 20,000 | +100.0% | 0.25% | +97.7% |
| Q4 2014 | $274,000 | – | 10,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empirical Capital Management, LLC | 479,018 | $9,298,000 | 8.38% |
| Rhenman & Partners Asset Management AB | 1,174,411 | $22,795,000 | 2.28% |
| Capital Investment Advisory Services, LLC | 153,842 | $2,986,000 | 1.40% |
| Cortina Asset Management, LLC | 1,238,420 | $24,038,000 | 1.12% |
| Investors Research Corp | 92,027 | $1,786,000 | 1.02% |
| Matarin Capital Management, LLC | 697,387 | $13,536,282,000 | 0.87% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 853,687 | $16,570,000 | 0.59% |
| RICE HALL JAMES & ASSOCIATES, LLC | 809,257 | $15,708,000 | 0.56% |
| BROADVIEW ADVISORS LLC | 156,700 | $3,042,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 3,535,217 | $68,619,000 | 0.44% |